Tomas Freiberger |
|
|
|
Centrum kardiovaskulární a transplantační chirurgie
·
Molecular Genetics Laboratory
|
| a |
| a |
| a |
| a |
27.88
Research experience
-
Jan 2010
Research: St. Ann's University Hospital Brno
St. Ann's University Hospital BrnoCzech Republic · Brno -
Jan 2002–
Dec 2012Research: Masarykova univerzita
Masarykova UniverzitaCzech Republic · Brno
Publications (40) View all
-
Article: [Opinion of the Czech Atherosclerosis Societys committee (CSAT) on the ESC/EAS guidlines related to the diagnostics and treatment of dyslipidemias issued in 2011].
V Soška, H Vaverková, M Vráblík, V Bláha, R Cífková, T Freiberger, P Kraml, J Piťha, H Rosolová, T Stulc, Z Urbanová[show abstract] [hide abstract]
ABSTRACT: This position statement of the Executive Committee of the Czech Society for Atherosclerosis (CSAT) summarizes the most important aspects and novelties of the latest European guidelines for the management of dyslipidemia. In particular the position statement comments on: cardiovascular risk stratification, indications for plasma lipid and lipoprotein levels assessment as well as target lipid values, evaluation of current options for both lifestyle and pharmacological treatment of lipid metabolism disorders and, also, recommendation for laboratory monitoring of patients treated with lipid lowering agents. The statement deals with actual concepts of management of dyslipiemia in everyday practice, e.g. therapy of dyslipidemia in special patients´ groups. This statement does not replace the latest guidelines but focuses on the changes from the former guidelines for dyslipidemia management, published by CSAT in 2007.Key words: dyslipidemia - risk stratification - LDL-cholesterol - statins - fibrates - niacin - ezetimibe - resins.Vnitr̆ní lékar̆ství 02/2013; 59(2):120-6. -
Article: Sequence variants of the TNFRSF13B gene in Czech CVID and IgAD patients in the context of other populations.
T Freiberger, B Ravčuková, L Grodecká, Z Pikulová, D Stikarovská, S Pešák, P Kuklínek, J Jarkovský, U Salzer, J Litzman[show abstract] [hide abstract]
ABSTRACT: Mutations in the TNFRSF13B gene, encoding TACI, have been found in common variable immunodeficiency (CVID) and selective IgA deficient (IgAD) patients, but only the association with CVID seems to be significant. In this study, Czech CVID, IgAD and primary hypo/dysgammaglobulinemic (HG/DG) patients were screened for all TNFRSF13B sequence variants. The TNFRSF13B gene was mutated in 4/70 CVID patients (5.7%), 9/161 IgAD patients (5.6%), 1/17 HG/DG patient (5.9%) and none of 195 controls. Eight different mutations were detected, including the most frequent p.C104R and p.A181E mutations as well as 1 novel missense mutation, p.R189K. A significant association of TNFRSF13B gene mutations was observed in both CVID (p=0.01) and IgAD (p=0.002) Czech patients. However, when combined with all published data, only the association with CVID remained significant compared with the controls (9.9% vs. 3.2%, p<10(-6)), while statistical significance disappeared for IgAD (5.7% vs. 3.2%, p=0.145). The silent mutation p.P97P was shown to be associated significantly with CVID compared with the controls in both Czech patients (allele frequency 4.3% vs. 0.2%, p=0.01) and in connection with the published data (5.1% vs. 1.8%, p=0.003). The relevance of some TNFRSF13B gene variants remains unclear and needs to be elucidated in future studies.Human immunology 08/2012; 73(11):1147-54. · 2.55 Impact Factor -
Article: Value of PCR in surgically treated patients with staphylococcal infective endocarditis: a 4-year retrospective study
B. Žaloudíková, E. Němcová, J. Pol, Z. Šorm, Š. Wurmová, K. Novotná, M. Vaněrková, V. Holá, F. Růžička, L. Dušek, P. Němec, T. Freiberger[show abstract] [hide abstract]
ABSTRACT: The aim of the study was to establish a diagnostic value for broad-range polymerase chain reaction (br-PCR) and staphylococci-specific multiplex PCR (ssm-PCR) performed on surgical material from patients with staphylococcal infective endocarditis (IE). Data were analysed retrospectively from 60 patients with suspected staphylococcal IE and 59 controls who were surgically treated at three cardiosurgery centres over 4 years. Both PCR tests showed high agreement and could be aggregated. In patients with definite and rejected IE, the clinical sensitivity and specificity of PCR reached 89 and 95%, respectively. Tissue culture (TC) and PCR agreed with blood culture (BC) in 29% and 67% of IE cases. TC helped to determine aetiology in five BC negative cases while PCR aided in nine cases. Out of 52 patients with conclusive staphylococcal IE, 40 were diagnosed with S. aureus and 12 with coagulase-negative staphylococci. PCR was shown to be highly superior to TC in confirming preoperative diagnosis of IE. In addition to aid in culture negative patients, PCR helped to establish or refine aetiology in inconclusive cases. We suggest that simultaneous br-PCR and ssm-PCR performed on surgical material together with histopathology could significantly increase the performance of current Duke criteria.European Journal of Clinical Microbiology 04/2012; · 2.86 Impact Factor -
Article: Value of PCR in surgically treated patients with staphylococcal infective endocarditis: a 4-year retrospective study.
B Zaloudíková, E Němcová, J Pol, Z Sorm, S Wurmová, K Novotná, M Vaněrková, V Holá, F Růžička, L Dušek, P Němec, T Freiberger[show abstract] [hide abstract]
ABSTRACT: The aim of the study was to establish a diagnostic value for broad-range polymerase chain reaction (br-PCR) and staphylococci-specific multiplex PCR (ssm-PCR) performed on surgical material from patients with staphylococcal infective endocarditis (IE). Data were analysed retrospectively from 60 patients with suspected staphylococcal IE and 59 controls who were surgically treated at three cardiosurgery centres over 4 years. Both PCR tests showed high agreement and could be aggregated. In patients with definite and rejected IE, the clinical sensitivity and specificity of PCR reached 89 and 95%, respectively. Tissue culture (TC) and PCR agreed with blood culture (BC) in 29% and 67% of IE cases. TC helped to determine aetiology in five BC negative cases while PCR aided in nine cases. Out of 52 patients with conclusive staphylococcal IE, 40 were diagnosed with S. aureus and 12 with coagulase-negative staphylococci. PCR was shown to be highly superior to TC in confirming preoperative diagnosis of IE. In addition to aid in culture negative patients, PCR helped to establish or refine aetiology in inconclusive cases. We suggest that simultaneous br-PCR and ssm-PCR performed on surgical material together with histopathology could significantly increase the performance of current Duke criteria.European Journal of Clinical Microbiology 10/2011; 31(6):1187-94. · 2.86 Impact Factor -
Article: Association of FcRn expression with lung abnormalities and IVIG catabolism in patients with common variable immunodeficiency.
T Freiberger, L Grodecká, B Ravcuková, B Kurecová, V Postránecká, J Vlcek, J Jarkovský, V Thon, J Litzman[show abstract] [hide abstract]
ABSTRACT: The neonatal Fc receptor (FcRn) acts as a key regulator of IgG homeostasis and is an important sensor of luminal infection. We analyzed the influence of FcRn expression on disease phenotype and the catabolism of therapeutically administered intravenous immunoglobulins (IVIG) in 28 patients with common variable immunodeficiency (CVID). Patients with generalized bronchiectasis and fibrosis had lower levels of FCRN mRNA compared to patients without these complications (P=0.027 and P=0.041, respectively). Moreover, FCRN mRNA levels correlated negatively with the extent of bronchiectasis and the rate of IgG decline after infusion of IVIG (P=0.027 and P=0.045, respectively). No relationship of FCRN expression with age at disease onset, age at diagnosis, diagnostic delay, IgG levels or frequency of infections before or during replacement immunoglobulin treatment, the presence of lung functional abnormalities, chronic diarrhea, granulomas, lymphadenopathy, splenomegaly or autoimmune phenomena was observed. Our results showed that FcRn might play a role in the development of lung structural abnormalities and in the catabolism of IVIG in patients with CVID.Clinical Immunology 09/2010; 136(3):419-25. · 4.05 Impact Factor